We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio CHICAGO — Patients repeatedly treated ...

- Results suggest that the extended duration of therapeutic benefit with DaxibotulinumtoxinA for Injection can produce dermal remodeling due to the prolonged period of muscle inactivity “The data ...

“ Dermatologic Surgery ’s publication of this new clinical data demonstrating the efficacy of Xeomin ® (incobotulinumtoxinA) will prove critical in encouraging physicians to consider Xeomin ® ...

Please provide your email address to receive an email when new articles are posted on . New phase 2 results showed 40 units of Jeuveau sustained improvements in glabellar lines up to 6 months. Adverse ...

October 26, 2010 (Chicago, Illinois) — The strain of botulinum toxin type A known as abobotulinumtoxinA or BoNTA-ABO (Dysport, Medicis) significantly reduces glabellar lines, a new study has shown.

DUBLIN, Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced clinical study results of higher doses of BOTOX ® Cosmetic compared to BOTOX ® Cosmetic 20 unit dose at week 24 in ...

South Korea's market leading neurotoxin in aesthetics set to launch in the second half of 2024. NEWPORT BEACH, Calif., March 4, 2024 /PRNewswire/ -- Hugel America, Inc., a division of Hugel Inc., a ...

NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the United States ...

–TrenibotE is a first-in-class botulinum neurotoxin serotype E characterized by a rapid onset of action as early as 8 hours after administration (earliest assessment time) and shorter duration of ...

“The data published in Dermatologic Surgery showed a substantial reduction in static glabellar lines and, despite subjects being required to return to baseline dynamic line severity between treatments ...